Posted by Michael Wonder on 30 Sep 2020
Schedule of Pharmaceutical Benefits - 1 October 2020 update
1 October 2020 - The October 2020 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.
The October issue of the Schedule includes a few new/revised listings:
- Aflibercept (Eylea) - new indication
- Amino acid formula with vitamins and minerals without phenylalanine (PKU Lophlex) - new formulation
- Apomorphine hydrochloride hemihydrate (Apomine, Apomine Intermittent, Movapo Pen) - restriction change
